Keith W. Pratz
Hematology
3400 Civic Center Boulevard
West Pavilion, 4th Floor
Philadelphia, PA 19104
West Pavilion, 4th Floor
Philadelphia, PA 19104
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 103 publications
Primary Cardioprotection in Frontline Anthracycline Therapy for Adult Hematologic Cancers.
Journal: JAMA network open
Published: August 24, 2026
Humoral influence on cytotoxicity in myeloid leukemia therapies.
Journal: Haematologica
Published: August 01, 2026
A real-world analysis of the impact of azole antifungal prophylaxis on outcomes in patients with newly diagnosed acute myeloid leukemia treated with venetoclax-based therapy.
Journal: Leukemia research
Published: October 06, 2025
Long-Term Outcomes of Stem Cell Transplant in Older Patients With Acute Myeloid Leukemia Treated With Venetoclax-Based Therapies.
Journal: American journal of hematology
Published: June 25, 2025
Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemia.
Journal: Blood cancer journal
Published: December 09, 2024
Advancing the outcomes of AML out of antecedent MPN by targeting mutated IDH1.
Journal: British journal of haematology
Published: December 03, 2024
Tumor Lysis Syndrome in Acute Myeloid Leukemia Patients Treated With a Venetoclax Based Regimen.
Journal: European journal of haematology
Published: September 22, 2024
Frontline Therapy of AML in the Fit and Younger Population-Incorporating Molecularly Targeted Agents.
Journal: American journal of hematology
Published: July 26, 2024
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults.
Journal: The New England journal of medicine
Published: July 24, 2024
Last Updated: 09/26/2026